Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Related Posts
Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi[...]
Ribeiro FC, Kemmerich KK, Gonçale JC, Junqueira JC, Mannan M, Nabeela S, Colombo AL, Uppuluri P. Candida albicans recovered from persistent candidemia exhibit enhanced virulence[...]
Nelson A, Bheemraj K, Dean SS, de Voux A, Hlatshwayo L, Mvududu R, Berkowitz N, Neumuller C, Jacobs S, Fourie S, Coates T, Gail-Bekker L,[...]